Literature DB >> 7599262

Poly(ethylene glycol)-modified phospholipids prevent aggregation during covalent conjugation of proteins to liposomes.

T O Harasym1, P Tardi, S A Longman, S M Ansell, M B Bally, P R Cullis, L S Choi.   

Abstract

Liposome aggregation is a major problem associated with the covalent attachment of proteins to liposomes. This report describes a procedure for coupling proteins to liposomes that results in little or no change in liposome size. This is achieved by incorporating appropriate levels of poly(ethylene glycol)-modified lipids into the liposomes. The studies employed thiolated avidin-D coupled to liposomes containing the thio-reactive lipid N-(4-(p-maleimidophenyl)butyryl)dipalmitoyl phosphatidylethanolamine (1 mol % of total lipid) and various amounts of MePEG-S-POPE (monomethoxypoly(ethylene glycol) linked to phosphatidylethanolamine via a succinate linkage). The influence of PEG chain length and density was also assessed. The presence of PEG on the surface of liposomes is shown to provide an effective method of inhibiting aggregation and the corresponding increase in liposome size during the covalent coupling of avidin-D. A balance between the size of the PEG used and the amount of PEG-lipid incorporated into the liposome had to be achieved in order to maintain efficient coupling. Optimal coupling efficiencies in combination with minimal aggregation effects were achieved using 2 mol % MePEG2000-S-POPE (PEG of 2000 MW) or 0.8 mol % MePEG5000-S-POPE (PEG of 5000 MW). At these levels, the presence of PEG did not affect the biotin binding activity of the covalently attached avidin. The ability of the resulting liposomes to specifically target to biotinylated cells is demonstrated.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7599262     DOI: 10.1021/bc00032a006

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  7 in total

1.  Receptor-specific targeting with liposomes in vitro based on sterol-PEG(1300) anchors.

Authors:  Markus Gantert; Felicitas Lewrick; Joanna E Adrian; Jochen Rössler; Thomas Steenpass; Rolf Schubert; Regine Peschka-Süss
Journal:  Pharm Res       Date:  2008-11-18       Impact factor: 4.200

2.  Oral vaccination with modified vaccinia virus Ankara attached covalently to TMPEG-modified cationic liposomes overcomes pre-existing poxvirus immunity from recombinant vaccinia immunization.

Authors:  Toshio Naito; Yutaro Kaneko; Danuta Kozbor
Journal:  J Gen Virol       Date:  2007-01       Impact factor: 3.891

3.  Recombinant and chemo-/bio-orthogonal synthesis of liposomal thrombomodulin and its antithrombotic activity.

Authors:  Lin Wang; Rui Jiang; Yang Liu; Maosheng Cheng; Qingyu Wu; Xue-Long Sun
Journal:  J Biosci Bioeng       Date:  2017-07-08       Impact factor: 2.894

4.  Experimental and Monte Carlo simulation studies of the thermodynamics of polyethyleneglycol chains grafted to lipid bilayers.

Authors:  S Rex; M J Zuckermann; M Lafleur; J R Silvius
Journal:  Biophys J       Date:  1998-12       Impact factor: 4.033

5.  Influence of PEG coating on the biodistribution and tumor accumulation of pH-sensitive liposomes.

Authors:  Shirleide Santos Nunes; Renata Salgado Fernandes; Carolina Henriques Cavalcante; Isabela da Costa César; Elaine Amaral Leite; Sávia Caldeira Araújo Lopes; Alice Ferretti; Domenico Rubello; Danyelle M Townsend; Mônica Cristina de Oliveira; Valbert Nascimento Cardoso; André Luís Branco de Barros
Journal:  Drug Deliv Transl Res       Date:  2019-02       Impact factor: 4.617

6.  Synthetic Liposomal Mimics of Biological Viruses for the Study of Immune Responses to Infection and Vaccination.

Authors:  Wei-Yun Wholey; James L Mueller; Corey Tan; Jeremy F Brooks; Julie Zikherman; Wei Cheng
Journal:  Bioconjug Chem       Date:  2020-01-23       Impact factor: 4.774

7.  PEGylated versus Non-PEGylated pH-Sensitive Liposomes: New Insights from a Comparative Antitumor Activity Study.

Authors:  Shirleide Santos Nunes; Juliana de Oliveira Silva; Renata Salgado Fernandes; Sued Eustaquio Mendes Miranda; Elaine Amaral Leite; Marcelo Alexandre de Farias; Rodrigo Villares Portugal; Geovanni Dantas Cassali; Danyelle M Townsend; Mônica Cristina Oliveira; André Luís Branco de Barros
Journal:  Pharmaceutics       Date:  2022-01-24       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.